Cited by 63Pain Mechanisms and TreatmentsCannabis and Cannabinoid ResearchOsteoarthritis Treatment and Mechanisms

The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.

A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis

Malek, Natalia, Mrugala, Monika, Makuch, Wioletta, Kolosowska, Natalia, Przewlocka, Barbara, Binkowski, Marcin, Czaja, Martyna, Morera, Enrico, Di Marzo, Vincenzo, Starowicz, Katarzyna·2015·Pain

Abstract

The pharmacological inhibition of anandamide (AEA) hydrolysis by fatty acid amide hydrolase (FAAH) attenuates pain in animal models of osteoarthritis (OA) but has failed in clinical trials. This may have occurred because AEA also activates transient receptor potential vanilloid type 1 (TRPV1), which contributes to pain development. Therefore, we investigated the effectiveness of the dual FAAH-TRPV1 blocker OMDM-198 in an MIA-model of osteoarthritic pain. We first investigated the MIA-induced model of OA by (1) characterizing the pain phenotype and degenerative changes within the joint using X-ray microtomography and (2) evaluating nerve injury and inflammation marker (ATF-3 and IL-6) expression in the lumbar dorsal root ganglia of osteoarthritic rats and differences in gene and protein expression of the cannabinoid CB1 receptors FAAH and TRPV1. Furthermore, we compared OMDM-198 with compounds acting exclusively on FAAH or TRPV1. Osteoarthritis was accompanied by the fragmentation of bone microstructure and destroyed cartilage. An increase of the mRNA levels of ATF3 and IL-6 and an upregulation of AEA receptors and FAAH in the dorsal root ganglia were observed. OMDM-198 showed antihyperalgesic effects in the OA model, which were comparable with those of a selective TRPV1 antagonist, SB-366,791, and a selective FAAH inhibitor, URB-597. The effect of OMDM-198 was attenuated by the CB1 receptor antagonist, AM-251, and by the nonpungent TRPV1 agonist, olvanil, suggesting its action as an "indirect" CB1 agonist and TRPV1 antagonist. These results suggest an innovative strategy for the treatment of OA, which may yield more satisfactory results than those obtained so far with selective FAAH inhibitors in human OA.

Overview

Integrity signals

Registry

Crossref · 10.1097/j.pain.0000000000000132

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

Sorted by citations

See all 63

Metadata

Authors
Malek, N., Mrugala, M., Makuch, W., Kolosowska, N., Przewlocka, B., Binkowski, M., Czaja, M., Morera, E., Di Marzo, V., & Starowicz, K.
Affiliations
  • University of Silesia in Katowice (PL)
  • Sapienza University of Rome (IT)
Corresponding author
Starowicz, Katarzyna
Venue
Pain
Published
2015-05
Volume
156
Issue
5
Pages
890-903
ISSN
0304-3959 (ISSN-L)
OpenAlex
W1996295130
Cited by
63
References
70
Citations by year
2026: 2 · 2025: 4 · 2024: 2 · 2023: 3 · 2022: 5 · 2021: 9 · 2020: 9 · 2019: 2 · 2018: 10 · 2017: 9 · 2016: 7 · 2015: 1
FWCI
6.64
Type
journal article
Language
en
Open access
closed
Locations
  • Pain (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
  • Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
  • Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
Keywords
osteoarthritis pain, anandamide, fatty acid amide hydrolase, TRPV1, CB1 receptor, dorsal root ganglia, ATF3, interleukin-6, antihyperalgesia, AM251, olvanil, endocannabinoid system
MeSH terms
Fatty Acid Amide Hydrolases, Amidohydrolases, Anilides, Animals, Arachidonic Acids, Benzamides, Capsaicin, Carbamates, Cinnamates, Disease Models, Animal, Ganglia, Spinal, Hyperalgesia, Inflammation, Lumbar Vertebrae, Male, Osteoarthritis, Pain, Pain Measurement, Piperidines, Pyrazoles, Interleukin-6, Gene Expression, Rats, Wistar, Receptor, Cannabinoid, CB1, TRPV Cation Channels, Rats, Activating Transcription Factor 3, Polyunsaturated Alkamides, Pain Management, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review